TOPICS
Myelodysplastic Syndromes: Developing Drug and Biological Products for Treatment
Submit Comments by 09/01/2025 Although you can comment on any guidance at any time (see
ReadmoreCybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions
Docket Number: FDA-2021-D-1158 Issued by: Center for Devices and Radiological Health Center for Biologics Evaluation
Readmore- 1
- 2